IPC Publication
A
HUMAN NECESSITIES
HEALTH; LIFE-SAVING; AMUSEMENT
A61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J 3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

Note(s) [2006.01]

  • This subclass covers the following subject matter, whether set forth as a composition (mixture), process of preparing the composition or process of treating using the composition:
    • Drug or other biological compositions which are capable of:
      • preventing, alleviating, treating or curing abnormal or pathological conditions of the living body by such means as destroying a parasitic organism, or limiting the effect of the disease or abnormality by chemically altering the physiology of the host or parasite (biocides A01N 25/00-A01N 65/00);
      • maintaining, increasing, decreasing, limiting, or destroying a physiological body function, e.g. vitamin compositions, sex sterilants, fertility inhibitors, growth promotors, or the like (sex sterilants for invertebrates, e.g. insects, A01N; plant growth regulators A01N 25/00-A01N 65/00);
      • diagnosing a physiological condition or state by an in vivo test, e.g. X-ray contrast or skin patch test compositions (measuring or testing processes involving enzymes or micro-organisms C12Q; in vitro testing of biological material, e.g. blood, urine, G01N, e.g. G01N 33/48);
    • Body treating compositions generally intended for deodorising, protecting, adorning or grooming a body, e.g. cosmetics, dentifrices, tooth filling materials.
  • Attention is drawn to the definitions of groups of chemical elements following the title of section C.
  • Attention is drawn to the notes in class C07, for example the notes following the title of the subclass C07D, setting forth the rules for classifying organic compounds in that class, which rules are also applicable, if not otherwise indicated, to the classification of organic compounds in A61K.
  • In this subclass, with the exception of group A61K 8/00, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.
  • Therapeutic activity of medicinal preparations is further classified in subclass A61P.
A61K 8/00
Cosmetics or similar toilet preparations [2006.01]

Note(s) [2006.01]

  • Use of cosmetics or similar toilet preparations is further classified in subclass A61Q.
A61K 8/02
•
characterised by special physical form [2006.01]
•

Note(s) [2006.01]

  • In this group, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication of the contrary, classification is made in the last appropriate place.
A61K 8/03
•
•
Liquid compositions with two or more distinct layers [2006.01]
A61K 8/04
•
•
Dispersions; Emulsions [2006.01]
A61K 8/06
•
•
•
Emulsions [2006.01]
A61K 8/11
•
•
Encapsulated compositions [2006.01]
A61K 8/14
•
•
Liposomes [2006.01]
A61K 8/18
•
characterised by the composition [2006.01]
•

Note(s) [2006.01]

  • In this group, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication of the contrary, classification is made in the last appropriate place.
A61K 8/19
•
•
containing inorganic ingredients [2006.01]
A61K 8/20
•
•
•
Halogens; Compounds thereof [2006.01]
A61K 8/21
•
•
•
•
Fluorides; Derivatives thereof [2006.01]
A61K 8/22
•
•
•
Peroxides; Oxygen; Ozone [2006.01]
A61K 8/23
•
•
•
Sulfur; Selenium; Tellurium; Compounds thereof [2006.01]
A61K 8/24
•
•
•
Phosphorus; Compounds thereof [2006.01]
A61K 8/25
•
•
•
Silicon; Compounds thereof [2006.01]
A61K 8/26
•
•
•
Aluminium; Compounds thereof [2006.01]
A61K 8/27
•
•
•
Zinc; Compounds thereof [2006.01]
A61K 8/28
•
•
•
Zirconium; Compounds thereof [2006.01]
A61K 8/29
•
•
•
Titanium; Compounds thereof [2006.01]
A61K 8/30
•
•
containing organic compounds [2006.01]
A61K 8/31
•
•
•
Hydrocarbons [2006.01]
A61K 8/33
•
•
•
containing oxygen [2006.01]
A61K 8/34
•
•
•
•
Alcohols [2006.01]
A61K 8/35
•
•
•
•
Ketones, e.g. quinones, benzophenone [2006.01]
A61K 8/36
•
•
•
•
Carboxylic acids; Salts or anhydrides thereof [2006.01]
A61K 8/362
•
•
•
•
•
Polycarboxylic acids [2006.01]
A61K 8/365
•
•
•
•
•
Hydroxycarboxylic acids; Ketocarboxylic acids [2006.01]
A61K 8/368
•
•
•
•
•
with carboxyl groups directly bound to carbon atoms of aromatic rings [2006.01]
A61K 8/37
•
•
•
•
Esters of carboxylic acids [2006.01]
A61K 8/38
•
•
•
•
Percompounds, e.g. peracids [2006.01]
A61K 8/39
•
•
•
•
Derivatives containing from 2 to 10 oxyalkylene groups [2006.01]
A61K 8/40
•
•
•
containing nitrogen (quinones containing nitrogen A61K 8/35) [2006.01]
A61K 8/41
•
•
•
•
Amines [2006.01]
A61K 8/42
•
•
•
•
Amides [2006.01]
A61K 8/43
•
•
•
•
Guanidines [2006.01]
A61K 8/44
•
•
•
•
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof [2006.01]
A61K 8/45
•
•
•
•
Derivatives containing from 2 to 10 oxyalkylene groups [2006.01]
A61K 8/46
•
•
•
containing sulfur (A61K 8/44 takes precedence) [2006.01]
A61K 8/49
•
•
•
containing heterocyclic compounds [2006.01]
A61K 8/55
•
•
•
containing phosphorus [2006.01]
A61K 8/58
•
•
•
containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus [2006.01]
A61K 8/60
•
•
•
Sugars; Derivatives thereof [2006.01]
A61K 8/63
•
•
•
Steroids; Derivatives thereof [2006.01]
•
•
•

Note(s) [2006.01]

  • This group covers steroids, as defined in Note (1) after the title of subclass C07J.
A61K 8/64
•
•
•
Proteins; Peptides; Derivatives or degradation products thereof [2006.01]
A61K 8/65
•
•
•
•
Collagen; Gelatin; Keratin; Derivatives or degradation products thereof [2006.01]
A61K 8/66
•
•
•
•
Enzymes [2006.01]
A61K 8/67
•
•
•
Vitamins [2006.01]
A61K 8/68
•
•
•
Sphingolipids, e.g. ceramides, cerebrosides, gangliosides [2006.01]
A61K 8/69
•
•
•
containing fluorine [2006.01]
A61K 8/70
•
•
•
•
containing perfluoro groups, e.g. perfluoroethers [2006.01]
A61K 8/72
•
•
containing organic macromolecular compounds [2006.01]
A61K 8/73
•
•
•
Polysaccharides [2006.01]
A61K 8/81
•
•
•
obtained by reactions involving only carbon-to-carbon unsaturated bonds [2006.01]
A61K 8/84
•
•
•
obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds [2006.01]
A61K 8/85
•
•
•
•
Polyesters [2006.01]
A61K 8/86
•
•
•
•
Polyethers [2006.01]
A61K 8/87
•
•
•
•
Polyurethanes [2006.01]
A61K 8/88
•
•
•
•
Polyamides [2006.01]
A61K 8/89
•
•
•
•
Polysiloxanes [2006.01]
A61K 8/891
•
•
•
•
•
saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone [2006.01]
A61K 8/892
•
•
•
•
•
•
modified by a hydroxy group, e.g. dimethiconol [2006.01]
A61K 8/893
•
•
•
•
•
•
modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone [2006.01]
A61K 8/894
•
•
•
•
•
•
modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol [2006.01]
A61K 8/895
•
•
•
•
•
containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone [2006.01]
A61K 8/896
•
•
•
•
•
containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate [2006.01]
A61K 8/897
•
•
•
•
•
•
containing halogen, e.g. fluorosilicones [2006.01]
A61K 8/898
•
•
•
•
•
•
containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine [2006.01]
A61K 8/899
•
•
•
•
•
•
containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol [2006.01]
A61K 8/90
•
•
•
Block copolymers (A61K 8/89 takes precedence) [2006.01]
A61K 8/91
•
•
•
Graft copolymers (A61K 8/89 takes precedence) [2006.01]
A61K 8/92
•
•
Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products [2006.01]
A61K 8/96
•
•
containing materials, or derivatives thereof, of undetermined constitution [2006.01]
A61K 8/97
•
•
•
of vegetable origin, e.g. plant extracts [2006.01]
A61K 8/98
•
•
•
of animal origin [2006.01]
A61K 8/99
•
•
•
from micro-organisms [2006.01]
A61K 9/00
Medicinal preparations characterised by special physical form [2006.01]
A61K 9/02
•
Suppositories; Bougies; Bases for suppositories or bougies (apparatus for making A61J 3/08; devices for introducing into the body A61M 31/00) [2006.01]
A61K 9/06
•
Ointments; Bases therefor (apparatus for making A61J 3/04) [2006.01]
A61K 9/08
•
Solutions [2006.01]
A61K 9/10
•
Dispersions; Emulsions [2006.01]
A61K 9/107
•
•
Emulsions [2006.01]
A61K 9/113
•
•
•
Multiple emulsions, e.g. oil-in-water-in-oil [2006.01]
A61K 9/12
•
•
Aerosols; Foams [2006.01]
A61K 9/127
•
•
Liposomes [2006.01]
A61K 9/133
•
•
•
Unilamellar vesicles [2006.01]
A61K 9/14
•
Particulate form, e.g. powders (microcapsules A61K 9/50) [2006.01]
A61K 9/16
•
•
Agglomerates; Granulates; Microbeadlets [2006.01]
A61K 9/18
•
•
Adsorbates [2006.01]
A61K 9/19
•
•
lyophilised [2006.01]
A61K 9/20
•
Pills, lozenges or tablets [2006.01]
A61K 9/22
•
•
Sustained or differential release type [2006.01]
A61K 9/24
•
•
•
Layered or laminated unitary dosage forms [2006.01]
A61K 9/26
•
•
•
Discrete particles in supporting matrix [2006.01]
A61K 9/28
•
•
Dragees; Coated pills or tablets [2006.01]
A61K 9/30
•
•
•
Organic coatings [2006.01]
A61K 9/32
•
•
•
•
containing solid synthetic polymers [2006.01]
A61K 9/34
•
•
•
•
containing natural gums or resins [2006.01]
A61K 9/36
•
•
•
•
containing carbohydrates or derivatives thereof (A61K 9/34 takes precedence) [2006.01]
A61K 9/38
•
•
•
•
containing proteins or derivatives thereof [2006.01]
A61K 9/40
•
•
•
•
•
Gelatin containing [2006.01]
A61K 9/42
•
•
•
•
containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate [2006.01]
A61K 9/44
•
•
printed, embossed, grooved, or perforated [2006.01]
A61K 9/46
•
•
effervescent [2006.01]
A61K 9/48
•
Preparations in capsules, e.g. of gelatin, of chocolate [2006.01]
A61K 9/50
•
•
Microcapsules (A61K 9/52 takes precedence) [2006.01]
A61K 9/51
•
•
•
Nanocapsules [2006.01]
A61K 9/52
•
•
Sustained or differential release type [2006.01]
A61K 9/54
•
•
•
containing discrete particles with coatings of different thicknesses or different materials [2006.01]
A61K 9/56
•
•
•
•
Organic coatings [2006.01]
A61K 9/58
•
•
•
•
•
containing solid synthetic polymers [2006.01]
A61K 9/60
•
•
•
•
•
containing natural gums or resins [2006.01]
A61K 9/62
•
•
•
•
•
containing carbohydrates or derivatives thereof (A61K 9/60 takes precedence) [2006.01]
A61K 9/64
•
•
•
•
•
containing proteins or derivatives thereof [2006.01]
A61K 9/66
•
•
•
containing emulsions, dispersions or solutions [2006.01]
A61K 9/68
•
chewing gum type [2006.01]
A61K 9/70
•
Web, sheet or filament bases [2006.01]
A61K 9/72
•
for smoking or inhaling [2006.01]

Note(s) [2006.01]

  • A composition, i.e. a mixture of two or more components, is classified in the last of groups A61K 31/00-A61K 47/00 that provides for at least one of these components. The components may be single compounds or other single ingredients.
  • Any part of a composition which is not identified by the classification according to Note (1), and which itself is determined to be novel and non-obvious, must also be classified in the last appropriate place in groups A61K 31/00-A61K 47/00. The part can be either a single component or a composition in itself.
  • Any part of a composition which is not identified by the classification according to Note (1) or (2), and which is considered to represent information of interest for search, may also be classified in the last appropriate place in groups A61K 31/00-A61K 47/00. This can for example be the case when it is considered of interest to enable searching of compositions using a combination of classification symbols. Such non-obligatory classification should be given as "additional information".
A61K 41/00
Medicinal preparations obtained by treating materials with wave energy or particle radiation (A61K 31/59 takes precedence) [2006.01]
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [2006.01]
A61K 50/00
Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ECG) or for transcutaneous drug administration [2006.01]
Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance. [6]
Indexing scheme associated with group A61K 36/00, relating to plant parts with medicinal activity. [2006.01]
A61K 125/00
Containing or obtained from roots, bulbs, tubers, corms or rhizomes [2006.01]
A61K 127/00
Containing or obtained from leaves [2006.01]
A61K 129/00
Containing or obtained from bark [2006.01]
A61K 131/00
Containing or obtained from seeds, nuts, fruits or grains [2006.01]
A61K 133/00
Containing or obtained from flowers or blossoms [2006.01]
A61K 135/00
Containing or obtained from stems, stalks, branches, twigs or shoots [2006.01]